GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

NCT04652076 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Carcinoma
Cervix Carcinoma

Interventions

DRUG: NP137
DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

NETRIS Pharma

Collaborators

[object Object]
[object Object]